Stock listing
LBRX Stock Price, News, Filings & Events — Lb Pharmaceuticals Inc
Selected listing: LBRX · NASDAQ · USD · US
This page tracks Lb Pharmaceuticals Inc's LBRX:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following LBRX:NASDAQ. LBRX:NASDAQ is the stock-level entry point for investors researching Lb Pharmaceuticals Inc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Lb Pharmaceuticals Inc (Ticker: LBRX) is a public company based in the United States, with a market capitalization of approximately $1 billion. The company focuses on developing innovative pharmaceutical solutions. Investors can find relevant information about Lb Pharmaceuticals and its market activities on the 6ix platform.

- Ticker
- LBRX:NASDAQ
- Asset type
- Stock
- Market cap
- $1.44B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Lb Pharmaceuticals Inc LBRX:NASDAQ stock context
This page tracks Lb Pharmaceuticals Inc's LBRX:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following LBRX:NASDAQ. LBRX:NASDAQ is the stock-level entry point for investors researching Lb Pharmaceuticals Inc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Lb Pharmaceuticals Inc (Ticker: LBRX) is a public company based in the United States, with a market capitalization of approximately $1 billion. The company focuses on developing innovative pharmaceutical solutions. Investors can find relevant information about Lb Pharmaceuticals and its market activities on the 6ix platform.
Latest news from Lb Pharmaceuticals Inc
LB Pharmaceuticals to Participate in Upcoming September Investor Events
September 3, 2026
LB Pharmaceuticals Appoints Joseph Miller as Chief Financial Officer
September 3, 2026
LB Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 11, 2026
LB Pharmaceuticals Announces $150 Million Private Placement
July 29, 2026
LB Pharmaceuticals Announces Accelerated Timing of Topline Results from the Phase 3 NOVA-2 Trial of LB-102 in Schizophrenia
July 22, 2026
Research Lb Pharmaceuticals Inc
Lb Pharmaceuticals Inc investor report
Review AI stock analysis and investor report context for LBRX:NASDAQ.
Lb Pharmaceuticals Inc company profile
View the public company page for Lb Pharmaceuticals Inc on 6ix.
Lb Pharmaceuticals Inc news
Read company news and market updates connected to Lb Pharmaceuticals Inc.
Lb Pharmaceuticals Inc investor events
Find investor webinars, events, and replay context for Lb Pharmaceuticals Inc.